Ali …. 65 years old C/O exercise intolerance for 2 years.

Slides:



Advertisements
Similar presentations
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Advertisements

Chest Infections Lawrence Pike.
New COPD GOLD Classification
C.O.P.D.. CHRONIC OBSTRUCTIVE PULMONARY DISEASE Definition Chronic Obstructive Pulmonary Disease (COPD) is a chronic slowly progressive disorder characterized.
COPD “Trying to Expire Not Expire” Dr Esyld Watson HST Emergency Medicine.
Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 13 Resistance-Training Strategies for Individuals with Chronic Obstructive Pulmonary.
Lesson 4 Care and Problems of the Respiratory System Respiratory system problems can affect the functioning of other body systems. Imagine not being able.
Professor of Respiratory Medicine
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
By: E. Salehifar Clinical Pharmacist
COPD (Chronic Obstructive Pulmonary Disease)
ASTHMA AND COPD By Jess Laidlaw. Overview 1)Asthma 2)COPD 3)Comparison.
Pathogenesis of Obstructive Airways Disease. © McGill Molson Medical Informatics Project 2002.
Disorders of the respiratory system. Respiratory structures such as the airways, alveoli and pleural membranes may all be affected by various disease.
Management of Patients With Chronic Pulmonary Disease.
COPD Alison Boland StR Respiratory medicine. Aims & Objectives Overview of COPD Recap basic knowledge Update on COPD Know when to use nebulisers and home.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
COPD Joshua Jewell. Epidemiology 8% of all individuals 10% age >40 6 th leading cause of death worldwide th in U.S. - >120,000 Expected 3 rd 2020.
Chronic Obstructive Pulmonary Disease and Asthma: All That Wheezes? Clifford Courville, MD Pulmonary, Allergy, and Critical Care.
Week 4: Asthma and COPD Dr Felix Woodhead Consultant Physician.
Pathology of chronic obstructive airway diseases
Part 2… COAD in the Emergency Department.
Obstructive and restrictive respiratory diseases
Bronchiectasis SS Visser, Pulmonology Internal Medicine UP.
Approach to bronchiectasis
Chronic Obstructive Pulmonary Disease
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
Chapter 14 Bronchiectasis
Normal Lung Tissue Name some diseases that affect the respiratory system: Asthma Bronchitis Lung cancer COPD Emphysema Pneumonia Pleuritis Common cold.
HSS CBL Health Problems Winter Welcome Get to know your peers and tutor… 1.5 hour session 2.5% participation 2.5% quiz (multiple choice) … and enjoy!
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Lesson 4 Care and Problems of the Respiratory System Respiratory system problems can affect the functioning of other body systems. Imagine not being able.
Copyright © 2008 Wolters Kluwer Health | Lippincott Williams & Wilkins Emphysema Abnormal distention of air spaces beyond the terminal bronchioles with.
يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11 بسم الله الرحمن الرحیم با سلام.
Chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease (COPD)  Permanent reduction in airflow in the lung  Caused by smoking,
Presentation 2: AIRWAY Emergency Care CLS 243 Dr.Bushra Bilal.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Respiratory Emergencies. Respiratory Failure A condition that occurs when respiratory A condition that occurs when respiratory system is unable to adequately.
Ali …. 65 years old C/O exercise intolerance for 2 years.
OBSTRUCTIVE AIRWAY DISEASE
Presentation 2: AIRWAY Dr. Bushra Bilal Dr. Miada Mahmoud Rady CLS 243.
Chronic Obstructive Pulmonary Disease (COPD) Dr. Rami M Adil Al-Hayali Assistant professor in medicine.
Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.
Percent Change in Age-Adjusted Death Rates, U.S., Proportion of 1965 Rate –59% –64% –35% +163% –7% Coronary.
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Disorders of the respiratory system 2. Bronchitis is an obstructive respiratory disease that may occur in both acute and chronic forms. Acute bronchitis:
Management of Patients With Chronic Pulmonary Disease
Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
David R. Bassett, Jr. chapter 21 Exercise, Asthma, and Pulmonary Disease.
COPD Department of Internal Medicine Yonsei University College of Medicine Jae Ho Chung.
COPD Emergency Department Junior Medical Staff Teaching August 2015.
Azithromycin – for better or worse in chronic lung infection? Professor Emma Baker Professor of Clinical Pharmacology St George's, University of London.
Asthma ( Part 1 ) Dr.kassim.M.sultan F.R.C.P. Objectives: 1-Define asthma 2-Identify its aggravating factors 3-Describe its clinical features 4-Illustrate.
Asthma and COPD Part 2.
Chronic Obstructive Pulmonary Disease Clinacal Pharmacy.
Chronic Obstructive Pulmonary Disease(COPD)
Chronic Obstructive Pulmonary Disease (COPD)
Management of Chronic Airflow Obstruction
Diseases of the respiratory system lecture 3
Asthma Presented by Qassim j. odaa Master M.S.N..
Disorders of the respiratory system
COPD Dr MAMATHA SARTHI GPST3.
PHARMACOTHERAPY - I PHCY 310
Chronic obstructive pulmonary disease
PHARMACOTHERAPY - I PHCY 310
Dr R Nadama MD MRCP(lond) MRCP(UK), FRCP(Lond), EDARM, FCCP
PHARMACOTHERAPY - I PHCY 310
Dr R Nadama MD MRCP(lond) MRCP(UK), FRCP(Lond), EDARM, FCCP
Presentation transcript:

Ali …. 65 years old C/O exercise intolerance for 2 years

History of occasional wheeze “slight cough for a while” “5 may be 10 years” Morning sputum most of the time Smoked on and off for 40 years / 1.5 packs No clubbing Wheeze and hyperinflation

FEV1 / FVC < 70 % Diffusing capacity (DLco) Kco reduced

Saleh 55 years smoked 60 since age 16 Barrel-shaped Liver 6th space Cough, expectoration, SOB 2 years FEV1 44% FEF 19% RV%TLC 200% FEV1 / FVC 60% Ventolin neb. 5mg----FEV1 INCREASED 140 ml (10%)

KCO 98% Allergic rhinitis and hypret. Turbinates SOB triggered strongly by dust and irritants A trial of Symbicort for 3 weeks FEV1 and FEF50 rose to 80% FEV1 relapsed to 64% but recovered

D.D. with asthma Age of onset History of atopy Eosinophilia and IgE Bullae Chronic respiratory failure Diffusing capacity Trial of inhaled corticosteroids

GOLD DEFINITION (2001) “Is a disease state characterized by airflow limitation that is not fully reversible. The airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases”.

GOLD Definition (2007) Incorporates the extrapulmonary manifestations Muscle wasting Cachexia Cardiac deconditioning Osteoporosis Depression Social isolation

DEFINITION OF CHRONIC BRONCHITIS “Chronic or recurrent expectoration which is present on most days for a minimum of 3 months a year for at least 2 successive years”.

DEFINITION OF EMPHYSEMA “Permanent destructive enlargement of airspaces distal to the terminal bronchioles without obvious fibrosis”. Workshop of NHLBI

Low PaO 2 Normal PaCO 2 Low PaO 2 High PaCO 2 pH acidotic or low normal HCO 3 raised

COMPLICATIONS Respiratory failure Cor pulmonale Bacterial colonisation Hemoptysis Pneumothorax Extrapulmonary

Summary of management Bronchodilation ipratropium 40 to 80 µcg q 6 hourly 0r Combivent Tiotropium 18 µcg q 24 hrs Salmetrol 50 µcg q 12 hrs Formoterol 9 µcg q 12 hrs Influenzae vaccine yearly Rehabilitation: Grade 3-5 S.O.B. ?? Nebulise higher doses of Salbutamol + Ipratropium Spacer as effective Inhaled corticosteroids for “frequent exacerbations” 500 µcg fluticasone HFA (Seretide) 800 µcg busesonide (Symbicort) Rinse throat Spacer Mucolytics every winter {

LONG –TERM REHABILITATION 1  Benefit independent of age, FEV 1, exercise capacity, PaO 2  walk test 25-40%  6 minutes walk + 60 metres  Only modest rise VO 2 peak  Well being +

LONG –TERM REHABILITATION 2  2 supervised + 1 unsupervised session  As little as 6 weeks (Max. 12 weeks)  min  Anaerobic (cycle, brisk walking) ?? Strength exercises  Lower limbs > upper limbs  Respiratory muscles: no effect  60 – 85% peak performance  Benefit maintained months without formal maintenance regimen

Bullectomy FEV 1 > 40% PaO 2, PaCO 2 near normal Normal V/Q scan in the surrounding lung

Lung volume reduction surgery LVRS FEV 1 and D LCO above 20% Predominantly upper lobe emphysema

Exacerbations  Viral infection followed by bacterial activity one third associated with virus (rhinovirus or influenza) bacterial colonisation (20 to 30% during remissions) (30 to 50% during exacerb.) Haemophilus influenzae & parainfluenzae Streptococcus pneumoniae Branhamella catarrhalis  Bronchospasm pollution or occupational  MINOR CAUSES pneumonia Lt or Rt cardiac failure pneumothorax

Life-threatening exacerbations  Deterioration of consciousness  Marked distress  Paradoxical thoracoabdominal movement  Worsening ABGs in spite of oxygen and bronchodilators ( 50 – 70 – 7.3 )  Other comorbidities  Social support

MANAGEMENT OF EXACERBATIONS Nebulize Ipratropium 250 ucg Salbutamol 5 mg O 2 24% or 2 l / min Prednisolone 40 mg daily ? Antibiotics ? Non-invasive ventilatory support ?

Antibiotics for exacerbations  Worsening of 2 out of 3 of the following : shortness of breath amount of sputum purulency of sputum  Amoxycillin / clavunate  Cephalosporin (eg. Cefuroxime)  Quinolone ---Ciprofloxacin ---Levofloxacin ---Moxifloxacin (Avalox)

BRONCHIECTASIS Permanent dilatation of the bronchi Cough Usually mucopurulent sputum Hemoptysis is common Clubbing uncommon Wheeze similar to asthma and COPD Crackles common

FB or adenoma INFECTION HYPOGAMMAGLOBULINEMIA 1RY CILIARY DYSKINESIA : sinusitis + male infertility CYSTIC FIBROSIS

H. Influenzae K.pneumoniae S.pneumoniae P.aeruginosa (associated with rapid decline of FEV1 S.aurius (cystic fibrosis)

Nebulized antibiotic therapy Gentamycin or tobramycin Twice daily